Trial Profile
Post-Marketing Surveillance Study on the Safety and Efficacy of Cymbalta (Duloxetine) on Diabetic Peripheral Neuropathic Pain Among Filipino Patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2014
Price :
$35
*
At a glance
- Drugs Duloxetine (Primary)
- Indications Diabetic neuropathies; Neuropathic pain
- Focus Adverse reactions
- Sponsors Boehringer Ingelheim
- 20 Aug 2014 New trial record